A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system

Background Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC research notes Jg. 8; H. 1; S. 608
Hauptverfasser:	Laios, Alexandros, Volpi, Davide, Tullis, Iain D. C., Woodward, Martha, Kennedy, Stephen, Pathiraja, Pubudu N. J., Haldar, Krishnayan, Vojnovic, Borivoj, Ahmed, Ahmed A.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 26.10.2015 BioMed Central Ltd Springer Nature B.V
Schlagworte:	Biomedical and Life Sciences Biomedicine Cancer Care and treatment Development and progression Endometrial cancer Female Fluorescence Fluorescent Dyes Genetic aspects Genital Neoplasms, Female - pathology Genital Neoplasms, Female - surgery Health aspects Humans Imaging systems Indocyanine Green Life Sciences Medical Imaging Medicine/Public Health Oncology, Experimental Patient outcomes Pilot Projects Prospective Studies Research Article Risk factors Sentinel Lymph Node Biopsy Spectrometry, Fluorescence Spectroscopy, Near-Infrared Near infrared fluorescence Optical imaging Indocyanine green Sentinel lymph node Gynaecological cancer Methylene blue
ISSN:	1756-0500, 1756-0500
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Background Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence. Methods A novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB. Results A total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed. Conclusions This study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer.
AbstractList	Background Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence. Methods A novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB. Results A total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed. Conclusions This study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer. Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence. A novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB. A total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed. This study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer. Background Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence. Methods A novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB. Results A total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed. Conclusions This study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer. Keywords: Gynaecological cancer, Sentinel lymph node, Near infrared fluorescence, Optical imaging, Indocyanine green, Methylene blue Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence.BACKGROUNDSentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence.A novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB.METHODSA novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB.A total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed.RESULTSA total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed.This study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer.CONCLUSIONSThis study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer. Background Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence. Methods A novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB. Results A total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed. Conclusions This study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer. Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the current practice in the UK is testing the accuracy of SLN detection using radioactive isotopes within the context of clinical trials. However, radioactive tracers pose significant logistic problems. We, therefore, conducted a pilot, observational study to assess the feasibility of a novel optical imaging device for SLN detection in gynaecological cancers using near infrared (NIR) fluorescence. A novel, custom-made, optical imaging system was developed to enable detection of multiple fluorescence dyes and allow simultaneous bright-field imaging during open surgery and laparoscopic procedures. We then evaluated the performance of the system in a prospective study of 49 women with early stage vulval, cervical and endometrial cancer who were scheduled to undergo complete lymphadenectomy. Clinically approved fluorescent contrast agents indocyanine green (ICG) and methylene blue (MB) were used. The main outcomes of the study included SLN mapping detection rates, false negative rates using the NIR fluorescence technique and safety of the procedures. We also examined the association between injection sites and differential lymphatic drainage in women with endometrial cancer by fluorescence imaging of ICG and MB. A total of 64 SLNs were detected during both open surgery and laparoscopy. Following dose optimisation and the learning phase, SLN detection rate approached 100 % for all cancer types with no false negatives detected. Fluorescence from ICG and MB detected para-aortic SLNs in women with endometrial cancer following uterine injection. Percutaneous SLN detection was also achieved in most women with vulval cancer. No adverse reactions associated with the use of either dyes were observed. This study demonstrated the successful clinical application of a novel NIR fluorescence imaging system for SLN detection across different gynaecological cancers. We showcased the first in human imaging, during the same procedure, of two fluorescence dyes in women with endometrial cancer.
ArticleNumber	608
Audience	Academic
Author	Ahmed, Ahmed A. Laios, Alexandros Tullis, Iain D. C. Vojnovic, Borivoj Woodward, Martha Pathiraja, Pubudu N. J. Haldar, Krishnayan Volpi, Davide Kennedy, Stephen
Author_xml	– sequence: 1 givenname: Alexandros surname: Laios fullname: Laios, Alexandros organization: Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Gynaecological Oncology Unit, Churchill Hospital, Oxford University Hospitals NHS Trust – sequence: 2 givenname: Davide surname: Volpi fullname: Volpi, Davide organization: Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford – sequence: 3 givenname: Iain D. C. surname: Tullis fullname: Tullis, Iain D. C. organization: Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford – sequence: 4 givenname: Martha surname: Woodward fullname: Woodward, Martha organization: Early Phase Research Hub, Department of Oncology, Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Trust – sequence: 5 givenname: Stephen surname: Kennedy fullname: Kennedy, Stephen organization: Nuffield Department of Obstetrics and Gynaecology, University of Oxford – sequence: 6 givenname: Pubudu N. J. surname: Pathiraja fullname: Pathiraja, Pubudu N. J. organization: Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Gynaecological Oncology Unit, Churchill Hospital, Oxford University Hospitals NHS Trust – sequence: 7 givenname: Krishnayan surname: Haldar fullname: Haldar, Krishnayan organization: Gynaecological Oncology Unit, Churchill Hospital, Oxford University Hospitals NHS Trust – sequence: 8 givenname: Borivoj surname: Vojnovic fullname: Vojnovic, Borivoj organization: Department of Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford – sequence: 9 givenname: Ahmed A. surname: Ahmed fullname: Ahmed, Ahmed A. email: ahmed.ahmed@obs-gyn.ox.ac.uk organization: Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Gynaecological Oncology Unit, Churchill Hospital, Oxford University Hospitals NHS Trust, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/26502876$$D View this record in MEDLINE/PubMed
BookMark	eNp9kstu1DAUhiNURC_wAGyQJTawSLFzc7JBGlVcKlXqpmJreZzj1JVjB9sZMX0KHpkTTSkzFSAvYsfff3zOr_80O3LeQZa9ZvScsbb5EFnJaJVTVues5k1-_yw7YbxuclpTerS3P85OY7yjtGFty15kx0VT06LlzUn2c0Wm4OMEKpkNkMlYn0hMc78lXpMe0nLh3XKI4JJxYIndjtMtcb6HSIwjw9ZJUN76wShpiZJOQYhkjsYNRCK3QY0DGRDWQQboibazDxAVIErMKIcFjduYYHyZPdfSRnj18D3Lbj5_urn4ml9df7m8WF3lqmLNfd6zqiw0b9u2031dNiXrmSoa3QJUTdFWHV1Xa6kpB6UBYE15B0WJMOsKraryLPu4KzvN6xF67CQFacUUsJuwFV4acXjjzK0Y_EZgddZyigXePRQI_vsMMYnR4EDWSgd-joLxgnfodtMh-vYJeufn4HA6pBDiFS_ZH2qQFgRa5fFdtRQVqxpnLmjZlUid_4XC1cNoFMZDG_x_IHh_IEAmwY80yDlGcXn97ZB9s2_Koxu_44IA2wEKMxMD6EeEUbFEUuwiKTCSYomkuEcNf6JRJsklVNi5sf9VFjtlxFfcAGHPt3-KfgGmq_cb
CitedBy_id	crossref_primary_10_1007_s00259_021_05445_6 crossref_primary_10_1016_j_remnie_2017_10_009 crossref_primary_10_1097_IGC_0000000000000996 crossref_primary_10_1177_1536012120962333 crossref_primary_10_1016_j_ejso_2020_05_015 crossref_primary_10_1186_s40644_022_00482_2 crossref_primary_10_1007_s11701_020_01170_8 crossref_primary_10_1007_s00404_019_05415_2 crossref_primary_10_3390_medicina58060792 crossref_primary_10_1155_2021_7594513 crossref_primary_10_2217_fon_2020_0370 crossref_primary_10_1002_jso_26469 crossref_primary_10_3390_cancers11121885 crossref_primary_10_1371_journal_pone_0174928 crossref_primary_10_1016_j_ajog_2016_11_1033 crossref_primary_10_3390_jcm10194387 crossref_primary_10_3390_ijerph19063716 crossref_primary_10_3390_jcm12052048 crossref_primary_10_1016_j_ajog_2021_05_034 crossref_primary_10_1016_j_jogoh_2024_102819 crossref_primary_10_3389_fonc_2021_652458 crossref_primary_10_1007_s00259_024_06713_x crossref_primary_10_23736_S1824_4785_21_03355_0 crossref_primary_10_3390_cancers14174184 crossref_primary_10_1186_s13550_022_00886_y crossref_primary_10_1016_j_ejogrb_2023_12_037 crossref_primary_10_1002_jso_25105 crossref_primary_10_1016_j_ajog_2025_04_052 crossref_primary_10_1515_nanoph_2018_0134 crossref_primary_10_1016_j_ygyno_2021_01_031
Cites_doi	10.1038/nrclinonc.2013.123 10.1016/j.ygyno.2011.08.034 10.1016/j.ygyno.2013.09.007 10.1177/548.6512 10.1097/IGC.0b013e3182a616f6 10.1016/S0001-2998(00)80058-6 10.1097/CCO.0b013e32832f3d53 10.1016/j.ygyno.2012.04.009 10.1016/j.ygyno.2008.05.032 10.1016/j.ygyno.2013.11.023 10.1097/IGC.0b013e31822b451d 10.1016/j.ygyno.2011.09.025 10.1111/1471-0528.12173 10.1016/j.ygyno.2012.08.018 10.1007/s00066-008-1728-3 10.1016/j.ygyno.2013.11.034 10.1016/j.ygyno.2010.10.009 10.1007/s11307-010-0425-7 10.1016/j.ygyno.2014.02.028 10.1016/j.ajog.2011.07.039 10.1016/j.ygyno.2009.01.003 10.1016/j.ygyno.2014.05.022 10.1016/j.ygyno.2013.08.018 10.1200/JCO.2007.13.8933 10.1200/JCO.2009.22.3248 10.1038/bjc.2014.205 10.1016/j.ejso.2014.02.228 10.1016/j.ygyno.2012.07.002
ContentType	Journal Article
Copyright	Laios et al. 2015 COPYRIGHT 2015 BioMed Central Ltd. Copyright BioMed Central 2015
Copyright_xml	– notice: Laios et al. 2015 – notice: COPYRIGHT 2015 BioMed Central Ltd. – notice: Copyright BioMed Central 2015
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1186/s13104-015-1576-z
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Biological Science ProQuest Databases ProQuest One Academic (New) Proquest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	1756-0500
ExternalDocumentID	PMC4621870 4017248101 A541620393 26502876 10_1186_s13104_015_1576_z
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: Cancer Research UK grantid: 16466 – fundername: Cancer Research UK grantid: C5255/A16466 – fundername: Medical Research Council grantid: G0902418 – fundername: Cancer Research UK grantid: 15677 – fundername: Cancer Research UK grantid: C5255/A15935
GroupedDBID	--- 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IEA IHR INH INR IOV ITC KQ8 LK8 M1P M48 M7P MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP ~8M AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM
ID	FETCH-LOGICAL-c416z-d1432f78889fd53631d1c26f8ee4628490b4baf07ecfeeeb079e2389f192fc43
IEDL.DBID	RSV
ISSN	1756-0500
IngestDate	Tue Nov 04 01:59:00 EST 2025 Thu Sep 04 18:06:11 EDT 2025 Sat Oct 11 05:42:38 EDT 2025 Tue Nov 11 10:01:12 EST 2025 Tue Nov 04 18:01:47 EST 2025 Thu Nov 13 15:50:56 EST 2025 Sat May 31 02:05:15 EDT 2025 Sat Nov 29 05:36:55 EST 2025 Tue Nov 18 21:40:41 EST 2025 Sat Sep 06 07:29:14 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Near infrared fluorescence Optical imaging Indocyanine green Sentinel lymph node Gynaecological cancer Methylene blue
Language	English
License	Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c416z-d1432f78889fd53631d1c26f8ee4628490b4baf07ecfeeeb079e2389f192fc43
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://link.springer.com/10.1186/s13104-015-1576-z
PMID	26502876
PQID	1779874731
PQPubID	55247
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_4621870 proquest_miscellaneous_1727988169 proquest_journals_1779874731 gale_infotracmisc_A541620393 gale_infotracacademiconefile_A541620393 gale_incontextgauss_IOV_A541620393 pubmed_primary_26502876 crossref_primary_10_1186_s13104_015_1576_z crossref_citationtrail_10_1186_s13104_015_1576_z springer_journals_10_1186_s13104_015_1576_z
PublicationCentury	2000
PublicationDate	20151026
PublicationDateYYYYMMDD	2015-10-26
PublicationDate_xml	– month: 10 year: 2015 text: 20151026 day: 26
PublicationDecade	2010
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	BMC research notes
PublicationTitleAbbrev	BMC Res Notes
PublicationTitleAlternate	BMC Res Notes
PublicationYear	2015
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V
References	AM Perrone (1576_CR25) 2008; 111 JR Vorst van der (1576_CR10) 2011; 21 R Sadeghi (1576_CR22) 2014; 132 JL Walker (1576_CR2) 2009; 27 BE Schaafsma (1576_CR13) 2013; 120 AL Vahrmeijer (1576_CR7) 2013; 10 G Mariani (1576_CR5) 2002; 43 H Niikura (1576_CR19) 2013; 131 J Fuller (1576_CR1) 2008; 184 LM Crane (1576_CR27) 2011; 13 C Meads (1576_CR6) 2014; 110 BE Schaafsma (1576_CR29) 2012; 127 N Furukawa (1576_CR26) 2010; 96 MH Oonk (1576_CR3) 2009; 21 PJ Bostick (1576_CR4) 2000; 30 EL Jewell (1576_CR21) 2014; 133 L Xiong (1576_CR23) 2014; 40 J How (1576_CR24) 2012; 127 C Altgassen (1576_CR16) 2008; 26 NR Abu-Rustum (1576_CR20) 2009; 113 EC Rossi (1576_CR28) 2012; 124 LMA Crane (1576_CR11) 2011; 120 1576_CR9 RW Holloway (1576_CR8) 2012; 126 EC Rossi (1576_CR12) 2013; 23 S Kang (1576_CR17) 2011; 123 D Volpi (1576_CR15) 2014; 8935 HM Matheron (1576_CR18) 2013; 131 M Frumovitz (1576_CR14) 2014; 132 AK Sinno (1576_CR30) 2014; 134
References_xml	– volume: 10 start-page: 507 issue: 9 year: 2013 ident: 1576_CR7 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2013.123 – volume: 123 start-page: 522 issue: 3 year: 2011 ident: 1576_CR17 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2011.08.034 – volume: 131 start-page: 720 issue: 3 year: 2013 ident: 1576_CR18 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2013.09.007 – volume: 96 start-page: 936 issue: 6 year: 2010 ident: 1576_CR26 publication-title: Tumori doi: 10.1177/548.6512 – volume: 23 start-page: 1704 issue: 9 year: 2013 ident: 1576_CR12 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0b013e3182a616f6 – volume: 30 start-page: 18 issue: 1 year: 2000 ident: 1576_CR4 publication-title: Semin Nucl Med doi: 10.1016/S0001-2998(00)80058-6 – volume: 21 start-page: 425 issue: 5 year: 2009 ident: 1576_CR3 publication-title: Curr Opin Oncol doi: 10.1097/CCO.0b013e32832f3d53 – volume: 126 start-page: 25 issue: 1 year: 2012 ident: 1576_CR8 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2012.04.009 – volume: 111 start-page: 62 issue: 1 year: 2008 ident: 1576_CR25 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2008.05.032 – volume: 132 start-page: 275 issue: 2 year: 2014 ident: 1576_CR14 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2013.11.023 – volume: 21 start-page: 1472 issue: 8 year: 2011 ident: 1576_CR10 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0b013e31822b451d – volume: 124 start-page: 78 issue: 1 year: 2012 ident: 1576_CR28 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2011.09.025 – volume: 120 start-page: 758 issue: 6 year: 2013 ident: 1576_CR13 publication-title: Bjog-Int J Obstet Gy doi: 10.1111/1471-0528.12173 – volume: 127 start-page: 332 issue: 2 year: 2012 ident: 1576_CR24 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2012.08.018 – volume: 184 start-page: 206 issue: 4 year: 2008 ident: 1576_CR1 publication-title: Strahlenther Onkol doi: 10.1007/s00066-008-1728-3 – volume: 43 start-page: 811 issue: 6 year: 2002 ident: 1576_CR5 publication-title: J Nucl Med – volume: 132 start-page: 273 issue: 2 year: 2014 ident: 1576_CR22 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2013.11.034 – volume: 120 start-page: 291 issue: 2 year: 2011 ident: 1576_CR11 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2010.10.009 – volume: 8935 start-page: 89350 year: 2014 ident: 1576_CR15 publication-title: Proc Spie – volume: 13 start-page: 1043 issue: 5 year: 2011 ident: 1576_CR27 publication-title: Mol Imaging Biol doi: 10.1007/s11307-010-0425-7 – volume: 133 start-page: 274 issue: 2 year: 2014 ident: 1576_CR21 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.02.028 – ident: 1576_CR9 doi: 10.1016/j.ajog.2011.07.039 – volume: 113 start-page: 163 issue: 2 year: 2009 ident: 1576_CR20 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2009.01.003 – volume: 134 start-page: 281 issue: 2 year: 2014 ident: 1576_CR30 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2014.05.022 – volume: 131 start-page: 299 issue: 2 year: 2013 ident: 1576_CR19 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2013.08.018 – volume: 26 start-page: 2943 issue: 18 year: 2008 ident: 1576_CR16 publication-title: J Clin Oncol doi: 10.1200/JCO.2007.13.8933 – volume: 27 start-page: 5331 issue: 32 year: 2009 ident: 1576_CR2 publication-title: J Clin Oncol doi: 10.1200/JCO.2009.22.3248 – volume: 110 start-page: 2837 issue: 12 year: 2014 ident: 1576_CR6 publication-title: Brit J Cancer doi: 10.1038/bjc.2014.205 – volume: 40 start-page: 843 issue: 7 year: 2014 ident: 1576_CR23 publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2014.02.228 – volume: 127 start-page: 126 issue: 1 year: 2012 ident: 1576_CR29 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2012.07.002
SSID	ssj0061881
Score	2.0396612
Snippet	Background Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological... Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological cancers, the... Background Sentinel Lymph Node (SLN) sampling may significantly reduce surgical morbidity by avoiding needless radical lymphadenectomy. In gynaecological...
SourceID	pubmedcentral proquest gale pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	608
SubjectTerms	Biomedical and Life Sciences Biomedicine Cancer Care and treatment Development and progression Endometrial cancer Female Fluorescence Fluorescent Dyes Genetic aspects Genital Neoplasms, Female - pathology Genital Neoplasms, Female - surgery Health aspects Humans Imaging systems Indocyanine Green Life Sciences Medical Imaging Medicine/Public Health Oncology, Experimental Patient outcomes Pilot Projects Prospective Studies Research Article Risk factors Sentinel Lymph Node Biopsy Spectrometry, Fluorescence Spectroscopy, Near-Infrared
SummonAdditionalLinks	– databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELegA4kXvgeBgQxCQgJZS5wPJ0-ooE0goTKhadqb5Th2qVSc0rST2r-CP5m7xCnLJPbCY-Vz0sudz3f23e8IeWO4Sk0mBLOwN7AksQnLlUmZqHgcZ1aXvD3TPfsqJpP8_Lw48QdujU-r7G1ia6irWuMZ-WEkBITHiYijD4tfDLtG4e2qb6Fxk-whUlkyInsfjyYn33tbnEV5Hvm7zCjPDpsIvBnMukhZBI422w52o6s2-dKmdDVh8sqtabsZHd_7Xzbuk7veDaXjTm8ekBvGPSS3u8aUm0fk95jCc_sqTLqYzesVbZFoaW1pZVZtApfDH1i8BJ7qnM43oBjU1ZVp6MzR6cYpo3vTSjVq17KhmGc_pQroLmCOg3UGxHaJafDUztf1soWX0obOfrb9k2gHNf2YnB4fnX76zHzvBqbBxduyCvwwbjG-LmyVxlkcVZHmmc2NwWrYpAjLpFQ2FEZbY0wZisKA91BY8DitTuJ9MnK1M08JtUUIJCoWcRwnKtdFqVQuyiRXYcFTnQck7EUotcc1x_Yac9nGN3kmO6lLkLpEqcttQN7tpiw6UI_riF-jXkgEy3CYjTNV66aRX76dyXEKvHKsbg7IW09ka3i5Vr64AVhAfK0B5cGAElazHg73eiO9NWnkX6UJyKvdMM7EDDln6jXScISei7IiIE86bd3xxsENh8g4C4gY6PGOADHGhyNu9qPFGgdhRWDSA_K-1_hLf-tfn-zZ9Uw8J3d4uwRDxrMDMlot1-YFuaUvVrNm-dIv4T-m01Jb priority: 102 providerName: ProQuest
Title	A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system
URI	https://link.springer.com/article/10.1186/s13104-015-1576-z https://www.ncbi.nlm.nih.gov/pubmed/26502876 https://www.proquest.com/docview/1779874731 https://www.proquest.com/docview/1727988169 https://pubmed.ncbi.nlm.nih.gov/PMC4621870
Volume	8
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: RBZ dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Journals New Starts & Take-Overs Collection customDbUrl: eissn: 1756-0500 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061881 issn: 1756-0500 databaseCode: RSV dateStart: 20081201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bixMxFD64uwq-eL-MriWKICjDzj2Zxyq7uKC1rEtZn0Imk9RCzSyddqH9Ff5kTzIzZaeooC-FNl9okjm3TM75AvBaRSJVGaW-Rt_gJ4lOfCZU6tMyiuNMyyJy73Qnn-hoxC4u8nFbx1132e7dkaSz1E6tWXZUhxiJ2IyJ1A8xSPY3e3CA3o5ZbTz7OunMbxYyFrbHl7_t1nNAu2b4mh_azZHcOSh1_ufk7n-N_B7cacNNMmzk4z7cUOYB3GouoFw_hJ9DgmPqqi3J5WxeLYljnCWVJqVaukQtY7_YIiWMSOdkvkYBIKYqVU1mhkzXRijZmVAirRQtamLz6adEIO4K-xjUJwTrhU13J3q-qhaORkoqMvvh7kkiDaX0Izg_OT7_8NFv72jwJYZyG7_EeCvSdh-d6zKNszgsQxllmillq16TPCiSQuiAKqmVUkVAc4VRQq4xstQyiR_DvqmMegpE5wFCREzjOE4Ek3khBKNFwkSQR6lkHgTdc-Oy5S-312jMudvHsIw368xxnbldZ77x4O22y2VD3vE38CsrDNySYhibdTMVq7rmp18mfJjiXCNbxezBmxakK_xzKdoiBpyC5dHqIQ97SNRa2W_uZI63VqPmIaU5w_1dHHrwcttse9pMOKOqlcVElmIuzHIPnjQiup1bhOE27oAzD2hPeLcAyyXebzGz745THB9WiKbbg3edCF8b1p-W7Nk_oZ_D7cjpQOBH2SHsLxcr9QJuyqvlrF4MYI9eUPfJBnDw_ng0Phu4FyQDm447xt_Gp5_H3wZO2X8BCYlOLQ
linkProvider	Springer Nature
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwELaWBQQX3o_AAgaBkEDWJs7DyQGhClhttaVwWK16sxzHLpVKUpp2Ufsr-CP8R2byKJtK7G0PHCuP244zz3jmG0JeGq5CEwnBLPgGFgQ2YLEyIRMZ9_3I6pRX73RPBmI4jEej5OsO-d32wmBZZWsTK0OdFRrfke97QkB6HAjfez_7wXBqFN6utiM0arE4MqufkLKV7_of4fm-4vzg0_GHQ9ZMFWAago81yyBC4BYzv8RmoR_5XuZpHtnYGOzTDBI3DVJlXWG0NcakrkgM-LXEQixkdeDD114il8GMC6wgE6NNfhd5cew1F6deHO2XHoROWOIRMg-ierbuuL5tB3DGA25XZ25d0Vae7-Dmf3Zmt8iNJsSmvVonbpMdk98hV-uhm6u75FePAhtthymdTabFglYou7SwNDOLqjgtxw_YmAVR-JROVyD0NC8yU9JJTserXBndug2qUXPmJcUegjFVQHcKe3JgHIjtHEv8qZ0ui3kFnaUNnXyvZkPRGkb7Hjm-iNO4T3bzIjcPCbWJCyTKF77vByrWSapULNIgVm7CQx07xG0lRuoGsx1Hh0xllbvFkayFTIKQSRQyuXbIm82WWQ1Ych7xCxRDiUAgOVYajdWyLGX_y4nshcArx85th7xuiGwBP65V07gBLCB2WIdyr0MJlkp3l1sxlY2lLOVfGXXI880y7sTqv9wUS6ThCKvnRYlDHtTKseGNQ4oBWX_kENFRmw0B4qd3V_LJtwpHHR6WB-7KIW9bBTvzt_51ZI_OZ-IZuXZ4_HkgB_3h0WNynVfa7zIe7ZHdxXxpnpAr-nQxKedPK9tBibxgvfsDIwutaA
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ri9QwEA96PvCL70f11CiCoJRr00fSj4u6eHisBx7LfQtpmqyFNV22uwe7f4V_sjN9LNdFBfHjkl_YJp2ZzDQzvyHkjWEqMSnnvoWzwY9jG_tCmcTnBYui1OqcNd90pyd8MhHn59lp1-e07rPd-yvJtqYBWZrc6mhR2FbFRXpUh-CVYPZE4ofgMPvbq-RajD2DMFz_Nu1NcRoKEXZXmb-dNjiM9k3ypTNpP19y79K0OYvGd_57FXfJ7c4NpaNWbu6RK8bdJzfaxpSbB-TniMLz9VWYdFHOqxVtmGhpZWlhVk0Cl8MfWLwEnuqczjcgGNRVhalp6ehs45TRvWmlGqVrWVPMs59RBbgLmONAzwBsl5gGT-18XS0beiltaPmj6Z9EW6rph-Rs_Onsw2e_693ga3Dxtn4BfhizGF9ntkiiNAqLULPUCmOwGjbOgjzOlQ240dYYkwc8M-A9ZBY8Tqvj6BE5cJUzTwi1WQAQFfEoimIldJYrJXgeCxVkLNHCI0H_DqXueM2xvcZcNvGNSGW7zxL2WeI-y61H3u2mLFpSj7-BX6NgSCTLcJiNM1PrupbHX6dylMBaGVY3e-RtB7IV_LlWXXEDLAH5tQbIwwEStFkPh3v5k501qWXIeSYg7otCj7zaDeNMzJBzplojhiH1XJhmHnnciutubQzccIiMU4_wgSDvAMgxPhxx5feGaxxeVggm3SPve3G-9Fh_2rKn_4R-SW6efhzLk-PJl2fkFmvUIfBZekgOVsu1eU6u64tVWS9fNLr9C4gEUvA
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+prospective+pilot+study+of+detection+of+sentinel+lymph+nodes+in+gynaecological+cancers+using+a+novel+near+infrared+fluorescence+imaging+system&rft.jtitle=BMC+research+notes&rft.au=Laios%2C+Alexandros&rft.au=Volpi%2C+Davide&rft.au=Tullis%2C+Iain+D.+C.&rft.au=Woodward%2C+Martha&rft.date=2015-10-26&rft.issn=1756-0500&rft.eissn=1756-0500&rft.volume=8&rft.issue=1&rft_id=info:doi/10.1186%2Fs13104-015-1576-z&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s13104_015_1576_z
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-0500&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-0500&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-0500&client=summon